Biofourmis

Biofourmis is a digital health company founded in 2015 by Kuldeep Singh Rajput and headquartered in Boston, Massachusetts. The company develops software and services for remote patient monitoring, hospital-at-home programs, and virtual care delivery, targeting health systems, pharmaceutical companies, and payers.

The company's core platform, Biovitals, uses biosensor data and machine learning models to detect physiological changes in patients with conditions such as heart failure, cancer, and post-surgical recovery. Biofourmis has partnered with health systems including Brigham and Women's Hospital and has worked with pharmaceutical companies to support decentralized clinical trials. Its hospital-at-home offering enables acute-level care to be delivered outside traditional inpatient settings.

Biofourmis raised a $300 million Series D round in 2021, bringing its total funding to approximately $445 million and valuing the company at over $1 billion. In 2022, the company acquired Curavi Health, a telehealth provider focused on skilled nursing facilities. The company has expanded operations across the United States, Europe, and Asia-Pacific.